Innovent Expands Internationally With Indonesia Deal

Licensing Agreement Reached With Etana For Byvasda Bevacizumab Biosimilar

 
• By Dave Wallace

Innovent Biologics has broadened its international reach by striking a licensing deal with PT Etana Biotechnologies in Indonesia for its Byvasda bevacizumab biosimilar.

Indonesia Map Magnifying Glass
Innovent has licensed bevacizumab to Etana in Indonesia • Source: Shutterstock

More from Biosimilars

More from Products